Investigational Site Number :6430004

Kazan' 420032

0 studies enrolling now · 2 studies all time

What they study most

Chronic Obstructive Pulmonary Disease, Primary Progressive Multiple Sclerosis

Studies at this site

• Primary Progressive Multiple Sclerosis (PPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (PERSEUS) — Completed
• Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate-to-severe COPD With Type 2 Inflammation — Completed